Table 2.
Clinicopathological characteristics.
| MANEC (n = 249) | Signet ring (n = 579) | GCC (n = 944) | Carcinoid (n = 950) | p-Value | |
|---|---|---|---|---|---|
| Grade, no. (%) | <0.0001* | ||||
| I. Well differentiated | 22 (9) | 18 (1) | 70 (7) | 174 (18) | |
| II. Moderately differentiated | 13 (12) | 36 (6) | 61 (7) | 40 (4) | |
| III. Poorly differentiated | 59 (24) | 297 (51) | 47 (5) | 7 (<1) | |
| IV. Undifferentiated, anaplastic | 9 (4) | 30 (5) | 2 (<1) | 4 (<1) | |
| Unknown | 128 (51) | 208 (36) | 764 (81) | 725 (76) | |
| Stage, no. (%) | <0.0001* | ||||
| I | 19 (8) | 27 (5) | 105 (22) | 212 (52) | |
| II | 107 (45) | 106 (20) | 302 (63) | 73 (18) | |
| III | 39 (16) | 90 (17) | 34 (7) | 84 (20) | |
| IV | 73 (30) | 317 (59) | 42 (9) | 31 (8) | |
| Median overall survival (years) | 6.5 | 2.1 | 13.8 | 39.4 | <0.0001* |
*Statistical significant p-value <0.05.